The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 737K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

26 articles for Z Nie


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of TAK-659 an orally available investigational inhibitor of Spleen Tyrosine Kinase (SYK).EBI
Takeda California
Discovery of TAK-960: an orally available small molecule inhibitor of polo-like kinase 1 (PLK1).EBI
Takeda California
Structure-based design and synthesis of novel macrocyclic pyrazolo[1,5-a] [1,3,5]triazine compounds as potent inhibitors of protein kinase CK2 and their anticancer activities.EBI
Polaris Pharmaceuticals
Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.EBI
Research Triangle Institute
Synthesis and transporter binding properties of 3beta-[4'-(phenylalkyl, -phenylalkenyl, and -phenylalkynyl)phenyl]tropane-2beta-carboxylic acid methyl esters: evidence of a remote phenyl binding domain on the dopamine transporter.EBI
Research Triangle Institute
Identification of Small Molecule Inhibitors and Ligand Directed Degraders of Calcium/Calmodulin Dependent Protein Kinase Kinase 1 and 2 (CaMKK1/2).EBI
Bristol Myers Squibb
Structure-based design, synthesis, and study of pyrazolo[1,5-a][1,3,5]triazine derivatives as potent inhibitors of protein kinase CK2.EBI
Polaris Pharmaceuticals
Pyrazolone structural motif in medicinal chemistry: Retrospect and prospect.EBI
Northwest University
Structure-based design, synthesis, and antimicrobial activity of indazole-derived SAH/MTA nucleosidase inhibitors.EBI
Quorex Pharmaceuticals
Discovery of CC-90011: A Potent and Selective Reversible Inhibitor of Lysine Specific Demethylase 1 (LSD1).EBI
Fount Therapeutics
Mechanism-based inactivation of thymidylate synthase by 5-(3-fluoropropyn-1-yl)-2'-deoxyuridine 5'-phosphate.EBI
State University of New York
Structure-based design and discovery of potent and selective lysine-specific demethylase 1 (LSD1) inhibitors.EBI
Celgene
Structure-based design and discovery of potent and selective KDM5 inhibitors.EBI
Celgene
MODULATORS OF PROGRAMMED DEATH-LIGAND-1BDB
Southern Research Institute
ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASEBDB
Petra Pharma
Monoacylglycerol lipase modulatorsBDB
Janssen Pharmaceutica
Indole derivatives and their use as protein kinase inhibitorsBDB
Respivert
Indazoles and use thereofBDB
Purdue Pharma
Inhibitors of c-fms kinaseBDB
Janssen Pharmaceutica
Substituted heteroaryl compounds and methods of useBDB
Calitor Sciences
Designing modulators of dimethylarginine dimethylaminohydrolase (DDAH): a focus on selectivity over arginase.BDB
Christian-Albrechts-University
Steroidal 5a-reductase inhibitors using 4-androstenedione as substrate.BDB
Metropolitan University-Xochimilco
Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activitiesBDB
Almirall
A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate.BDB
Whitehead Institute For Biomedical Research
Substituted pyridazine carboxamide compoundsBDB
Xcovery Holding
Small Molecule Inhibitors of 8-Oxoguanine DNA Glycosylase-1 (OGG1).BDB
Oregon Health & Science University